These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

526 related items for PubMed ID: 18514353

  • 1. Formulation of rifampicin-cyclodextrin complexes for lung nebulization.
    Tewes F, Brillault J, Couet W, Olivier JC.
    J Control Release; 2008 Jul 14; 129(2):93-9. PubMed ID: 18514353
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Preparation and characterization of inclusion complexes of prazosin hydrochloride with beta-cyclodextrin and hydroxypropyl-beta-cyclodextrin.
    Liu L, Zhu S.
    J Pharm Biomed Anal; 2006 Jan 23; 40(1):122-7. PubMed ID: 16095859
    [Abstract] [Full Text] [Related]

  • 5. Inclusion complexes of tadalafil with natural and chemically modified beta-cyclodextrins. I: preparation and in-vitro evaluation.
    Badr-Eldin SM, Elkheshen SA, Ghorab MM.
    Eur J Pharm Biopharm; 2008 Nov 23; 70(3):819-27. PubMed ID: 18655829
    [Abstract] [Full Text] [Related]

  • 6. New "drug-in cyclodextrin-in deformable liposomes" formulations to improve the therapeutic efficacy of local anaesthetics.
    Maestrelli F, González-Rodríguez ML, Rabasco AM, Ghelardini C, Mura P.
    Int J Pharm; 2010 Aug 16; 395(1-2):222-31. PubMed ID: 20594944
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Melarsoprol-cyclodextrins inclusion complexes.
    Gibaud S, Zirar SB, Mutzenhardt P, Fries I, Astier A.
    Int J Pharm; 2005 Dec 08; 306(1-2):107-21. PubMed ID: 16253447
    [Abstract] [Full Text] [Related]

  • 9. Characterization and in vitro evaluation of the formoterol/cyclodextrin complex for pulmonary administration by nebulization.
    Thi TH, Azaroual N, Flament MP.
    Eur J Pharm Biopharm; 2009 May 08; 72(1):214-8. PubMed ID: 19010412
    [Abstract] [Full Text] [Related]

  • 10. Use of cyclodextrins as solubilizing agents for simvastatin: effect of hydroxypropyl-β-cyclodextrin on lactone/hydroxyacid aqueous equilibrium.
    Ungaro F, Giovino C, Catanzano O, Miro A, Mele A, Quaglia F, La Rotonda MI.
    Int J Pharm; 2011 Feb 14; 404(1-2):49-56. PubMed ID: 21056648
    [Abstract] [Full Text] [Related]

  • 11. Cyclodextrins: Efficient biocompatible solubilizing excipients for bromhexine liquid and semi-solid drug delivery systems.
    Stojanov M, Nielsen HM, Larsen KL.
    Int J Pharm; 2012 Jan 17; 422(1-2):349-55. PubMed ID: 22027391
    [Abstract] [Full Text] [Related]

  • 12. Hydroxypropyl methylcellulose microspheres with piroxicam and piroxicam-hydroxypropyl-beta-cyclodextrin inclusion complex.
    Jug M, Bećirević-Laćan M, Cetina-Cizmek B, Horvat M.
    Pharmazie; 2004 Sep 17; 59(9):686-91. PubMed ID: 15497750
    [Abstract] [Full Text] [Related]

  • 13. Fosinopril-cyclodextrin inclusion complexes: phase solubility and physicochemical analysis.
    Sbârcea L, Udrescu L, Drăgan L, Trandafirescu C, Szabadai Z, Bojiţă M.
    Pharmazie; 2011 Aug 17; 66(8):584-9. PubMed ID: 21901980
    [Abstract] [Full Text] [Related]

  • 14. Insulin-loaded PLGA/cyclodextrin large porous particles with improved aerosolization properties: in vivo deposition and hypoglycaemic activity after delivery to rat lungs.
    Ungaro F, d'Emmanuele di Villa Bianca R, Giovino C, Miro A, Sorrentino R, Quaglia F, La Rotonda MI.
    J Control Release; 2009 Apr 02; 135(1):25-34. PubMed ID: 19154761
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Nebulization performance of biodegradable sildenafil-loaded nanoparticles using the Aeroneb Pro: formulation aspects and nanoparticle stability to nebulization.
    Beck-Broichsitter M, Kleimann P, Gessler T, Seeger W, Kissel T, Schmehl T.
    Int J Pharm; 2012 Jan 17; 422(1-2):398-408. PubMed ID: 22001839
    [Abstract] [Full Text] [Related]

  • 17. Effect of hydroxypropyl-beta-cyclodextrin on the solubility, stability and in-vitro release of ciprofloxacin for ocular drug delivery.
    Bozkir A, Denli ZF, Basaran B.
    Acta Pol Pharm; 2012 Jan 17; 69(4):719-24. PubMed ID: 22876616
    [Abstract] [Full Text] [Related]

  • 18. Physico-chemical characterization of disoxaril-dimethyl-beta-cyclodextrin inclusion complex and in vitro permeation studies.
    Ventura CA, Giannone I, Musumeci T, Pignatello R, Ragni L, Landolfi C, Milanese C, Paolino D, Puglisi G.
    Eur J Med Chem; 2006 Feb 17; 41(2):233-40. PubMed ID: 16387393
    [Abstract] [Full Text] [Related]

  • 19. Effect of 2-hydroxypropyl-beta-cyclodextrin on the solubility, stability, and pharmacological activity of the chemical delivery system of TRH analogs.
    Wu WM, Wu J, Bodor N.
    Pharmazie; 2002 Feb 17; 57(2):130-4. PubMed ID: 11878189
    [Abstract] [Full Text] [Related]

  • 20. Supramolecular interactions between losartan and hydroxypropyl-β-CD: ESI mass-spectrometry, NMR techniques, phase solubility, isothermal titration calorimetry and anti-hypertensive studies.
    de Paula WX, Denadai AM, Santoro MM, Braga AN, Santos RA, Sinisterra RD.
    Int J Pharm; 2011 Feb 14; 404(1-2):116-23. PubMed ID: 21093554
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 27.